Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

LLLT promotes hair growth and improves hair density safely in men and women.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Androgens may block hair growth signals, targeting this could treat hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Citrullus colocynthis fruit extract may effectively treat testosterone-related hair loss, similar to finasteride.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Dermoscopy is useful for diagnosing hair loss patterns in dogs.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Many alopecia patients have undetected thyroid abnormalities that can be found through physical exams.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

White and yellow dots indicate severe female hair loss in dark skin.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.